Pharmacotherapeutic Consequences of Recent Advances in Hemodialysis Therapy
- 1 April 1994
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 28 (4) , 512-514
- https://doi.org/10.1177/106002809402800415
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Vancomycin redistribution: Dosing recommendations following highflux hemodialysisKidney International, 1994
- Isepamicin disposition in subjects with various degrees of renal functionAntimicrobial Agents and Chemotherapy, 1991
- Mortality and Duration of Hemodialysis TreatmentJAMA, 1991
- Pharmacokinetics of cefepime in subjects with renal insufficiencyClinical Pharmacology & Therapeutics, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzersKidney International, 1989
- Pharmacological Considerations for Renal Failure and DialysisPublished by Springer Nature ,1989
- DialysersPublished by Springer Nature ,1989
- Haemodialysis: A Historical ReviewPublished by Springer Nature ,1989
- Effect of the Hemodialysis Prescription on Patient MorbidityNew England Journal of Medicine, 1981